BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

9815	Companies
196872	Keywords
127929	Articles
104694	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 09/02/2025 at 09:10, 5 months 3 days ago

BioNxt commence le développement à l'échelle du laboratoire d'un film oral à base de sémaglutide

Solutions BioNxt Administration De Médicaments Semaglutide ODF Formulation À L'échelle Du Laboratoire Développement De Brevets
BRIEF

published on 09/02/2025 at 09:10, 5 months 3 days ago

BioNxt Begins Lab-Scale Development of Semaglutide Oral Film

Drug Delivery BioNxt Solutions Semaglutide ODF Lab-scale Formulation Patent Development
PRESS RELEASE

published on 09/02/2025 at 09:05, 5 months 3 days ago

Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt
BioNxt Solutions announces receipt of Semaglutide API for laboratory-scale testing of ODF delivery system. Collaboration with Gen Plus for European drug development hub

BioNxt Solutions Semaglutide API ODF Delivery System Laboratory-scale Testing Gen Plus
BRIEF

published on 08/23/2025 at 02:10, 5 months 13 days ago

BioNxt Solutions s'engage dans des initiatives de relations avec les investisseurs

Relations Avec Les Investisseurs Visibilité De La Marque Solutions BioNxt Apaton Finance Cayo Ventures
BRIEF

published on 08/23/2025 at 02:10, 5 months 13 days ago

BioNxt Solutions Engages in Investor Relations Initiatives

Brand Visibility Investor Relations BioNxt Solutions Apaton Finance Cayo Ventures
PRESS RELEASE

published on 08/23/2025 at 02:05, 5 months 13 days ago

Promotional Activity Engagements
BioNxt Solutions Inc. engages Apaton Finance GmbH and Cayo Ventures GmbH for investor relations services. Apaton to enhance brand visibility, Cayo for digital marketing to drive website traffic

Digital Marketing Investor Relations BioNxt Solutions Inc. Apaton Finance GmbH Cayo Ventures GmbH
BRIEF

published on 08/20/2025 at 09:10, 5 months 16 days ago

BioNxt Solutions Accelerates U.S. Patent and Secures Broad IP for Neurological Autoimmune Disorders

Cladribine BioNxt Solutions U.S. Patent MS Treatment Sublingual Thin-Film
BRIEF

published on 08/20/2025 at 09:10, 5 months 16 days ago

BioNxt Solutions accélère l'obtention d'un brevet américain et obtient une large propriété intellectuelle pour les maladies neurologiques auto-immunes

Brevet Américain Cladribine Solutions BioNxt Couche Mince Sublinguale Traitement De La Sclérose En Plaques
PRESS RELEASE

published on 08/20/2025 at 09:05, 5 months 16 days ago

BioNxt Fast-Tracks U.S. Patent for MS Drug and Secures Broad Platform IP Covering Autoimmune Neurology Pipeline
BioNxt announces fast-tracked U.S. patent filing for BNT23001 sublingual thin-film cladribine formulation targeting neurological autoimmune disorders. Broad international patent core claims accepted for platform-level protection

Autoimmune Diseases Drug Delivery Neurological Disorders Patent Filing BioNxt
BRIEF

published on 08/09/2025 at 01:05, 5 months 27 days ago

BioNxt Solutions Completes Oversubscribed Convertible Debenture Offering

Private Placement Convertible Debenture Warrants Product Development BioNxt Solutions

Accesswire

Published on 02/05/2026 at 17:35, 56 minutes ago

Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 1 hour 51 minutes ago

Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 2 hours 46 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 3 hours 21 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 3 hours 41 minutes ago

High Tide Resources Announces Non-Brokered Private Placements

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 18:09, 22 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 36 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 51 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 17:40, 51 minutes ago

UV GERMI : MISE À DISPOSITION DE LA NOTE D’INFORMATION ET DU DOCUMENT « AUTRES INFORMATIONS » DANS LE CADRE DE L’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI
Published on 02/05/2026 at 17:05, 1 hour 26 minutes ago

European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels

Les Echos

Published on 02/05/2026 at 18:12, 19 minutes ago

LNA SANTE : Chiffre d'affaires annuel 2025
Published on 02/05/2026 at 18:06, 24 minutes ago

Aéroports de Paris SA - Actions et droits de vote au 31 janvier 2026
Published on 02/05/2026 at 18:06, 24 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Published on 02/05/2026 at 18:00, 31 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026
Published on 02/05/2026 at 18:00, 31 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 janvier 2026

View all LES ECHOS COMFI WIRE